The PE Ratio as of November 2024 (TTM) for Vaccitech plc (VACC) is -3.45

According to Vaccitech plc’s latest financial reports and current stock price. The company's current PE Ratio is -3.45. This represents a change of 167.75% compared to the average of -1.29 of the last 4 quarters.

Vaccitech plc (VACC) Historical PE Ratio (quarterly & annually)

How has VACC PE Ratio performed in the past?

The mean historical PE Ratio of Vaccitech plc over the last ten years is 1.23. The current -3.45 PE Ratio has changed -28068.09% with respect to the historical average. Over the past ten years (40 quarters), VACC's PE Ratio was at its highest in in the March 2022 quarter at 19.20. The PE Ratio was at its lowest in in the September 2021 quarter at -30.09.

Vaccitech plc (VACC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vaccitech plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vaccitech plc (VACC) Average PE Ratio

How has VACC PE Ratio performed in the past?

The current PE Ratio of Vaccitech plc (VACC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vaccitech plc (VACC) PE Ratio vs. Peers

How is VACC’s PE Ratio compared to its peers?

Vaccitech plc’s PE Ratio is less than Molecular Partners AG (-3.01), greater than MediciNova, Inc. (-10.09), greater than Anebulo Pharmaceuticals, Inc. (-5.95), greater than Champions Oncology, Inc. (-16.97), greater than Cyteir Therapeutics, Inc. (-3.52), greater than Edgewise Therapeutics, Inc. (-27.83), less than Talaris Therapeutics, Inc. (-0.20), less than Adicet Bio, Inc. (-0.83), greater than Cullinan Oncology, Inc. (-6.16), less than Vor Biopharma Inc. (-0.45), greater than Tyra Biosciences, Inc. (-11.91), greater than Third Harmonic Bio, Inc. (-27.19), greater than C4 Therapeutics, Inc. (-4.26), greater than Stoke Therapeutics, Inc. (-7.05), greater than Revolution Medicines, Inc. (-17.77), greater than Design Therapeutics, Inc. (-5.95), less than Achilles Therapeutics plc (-0.64), less than Neoleukin Therapeutics, Inc. (-0.98), less than Magenta Therapeutics, Inc. (-0.04), less than Graphite Bio, Inc. (-0.13), less than CytomX Therapeutics, Inc. (7.73), less than Instil Bio, Inc. (-1.50), less than Spero Therapeutics, Inc. (3.99), less than Assembly Biosciences, Inc. (-2.10),

Build a custom stock screener for Vaccitech plc (VACC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccitech plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaccitech plc (VACC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaccitech plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.